Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab. - Ohara M; Suda G; Kohya R; Yasui Y; Tsuchiya K; Kurosaki M; Tani J; Maekawa S; Enomoto N; Chuma M; Morimoto M; Kaneko S; et al. (Hepatology international, 2025)